Contact us

ESH Video

#ESHCART2023 STARTS IN 3 WEEKS: REGISTER NOW!

2^nd How I Manage
CAR-T Therapies and Bispecific Antibodies for my Patients

September 29 - October 1, 2023
Berlin, Germany
#ESHCART2023

Chairpersons: Ulrich Jäger (Vienna),
Marie José Kersten (Amsterdam), Loretta Nastoupil (Houston)

Words from Loretta Nastoupil, co-chair of the conference

Join Prof. Nastoupil, her co-chairs and the international faculty
in Berlin in only 3 weeks!
IT'S TIME TO REGISTER:

MEET THE FACULTY

About the Conference:

CAR-T cells and bispecific antibodies have advanced our therapeutic armamentarium for haematological malignancies. The programme of this ESH conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies will also be discussed.

Read more...

CONFERENCE MAIN SCIENTIFIC TOPICS:

- Non-hodgkin lymphoma (NHL)
- Multiple myeloma
- Novel indications CAR T-cell therapy
- Managing toxicity of CAR-T and bispecific antibody treatment
- Real world data CAR-T
- Life after CAR T-cell therapy

PROGRAMME - ACCOMMODATION - MORE INFORMATION

With the support of*:

Major Conference Partners
*******

Supporting Conference Partner
*******

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.